468 related articles for article (PubMed ID: 19114887)
1. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
4. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin.
Mukhtar A; Aboulfetouh F; Obayah G; Salah M; Emam M; Khater Y; Akram R; Hoballah A; Bahaa M; Elmeteini M; Hamza A
Anesth Analg; 2009 Sep; 109(3):924-30. PubMed ID: 19690268
[TBL] [Abstract][Full Text] [Related]
5. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients.
Van der Linden PJ; De Hert SG; Daper A; Trenchant A; Schmartz D; Defrance P; Kimbimbi P
Can J Anaesth; 2004 Mar; 51(3):236-41. PubMed ID: 15010405
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis.
Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D
Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
[TBL] [Abstract][Full Text] [Related]
10. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions].
Vogt N; Bothner U; Georgieff M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 May; 29(3):150-6. PubMed ID: 7519062
[TBL] [Abstract][Full Text] [Related]
13. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
[TBL] [Abstract][Full Text] [Related]
14. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
15. Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients.
Boldt J; Mayer J; Brosch C; Lehmann A; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):399-407. PubMed ID: 20510247
[TBL] [Abstract][Full Text] [Related]
16. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
17. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients.
Haisch G; Boldt J; Krebs C; Suttner S; Lehmann A; Isgro F
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):316-21. PubMed ID: 11426361
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery.
Järvelä K; Koskinen M; Kaukinen S; Kööbi T
J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):210-5. PubMed ID: 11312481
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery.
Thompson LD; McElhinney DB; Findlay P; Miller-Hance W; Chen MJ; Minami M; Petrossian E; Parry AJ; Reddy VM; Hanley FL
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):220-8. PubMed ID: 11479493
[TBL] [Abstract][Full Text] [Related]
20. Effect of volume replacement with hydroxyethyl starch solution on splanchnic oxygenation in patients undergoing cytoreductive surgery for ovarian cancer.
Guo X; Xu Z; Ren H; Luo A; Huang Y; Ye T
Chin Med J (Engl); 2003 Jul; 116(7):996-1000. PubMed ID: 12890370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]